These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19966877)

  • 21. Coexistent hereditary and inflammatory neuropathy.
    Ginsberg L; Malik O; Kenton AR; Sharp D; Muddle JR; Davis MB; Winer JB; Orrell RW; King RH
    Brain; 2004 Jan; 127(Pt 1):193-202. PubMed ID: 14607795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
    Nosadini M; Mohammad SS; Suppiej A; Sartori S; Dale RC;
    Dev Med Child Neurol; 2016 Nov; 58(11):1180-1192. PubMed ID: 27242065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic vocal cord palsies and associated neurological conditions.
    Urquhart AC; St Louis EK
    Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1086-9. PubMed ID: 16365222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spectrum of peripheral neuropathy in eastern India.
    Ghosh B; Sengupta S; Bhattacharjee R; Pal S; Saha SP; Ganguly G; Ganguly PK; Das SK; Roy T
    J Indian Med Assoc; 2006 Apr; 104(4):168, 170-3. PubMed ID: 16910321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy with intravenous immunoglobulins: complications and side-effects.
    Wittstock M; Benecke R; Zettl UK
    Eur Neurol; 2003; 50(3):172-5. PubMed ID: 14530624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis.
    Hartung HP; Reiners K; Schmidt B; Stoll G; Toyka KV
    Ann Neurol; 1991 Jul; 30(1):48-53. PubMed ID: 1929228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of high dose intravenous immunoglobulin in neurologic disease].
    Korsak J; Zaleska B; Orłowska E; Kotowicz J
    Pol Merkur Lekarski; 2005 Jul; 19(109):98-101. PubMed ID: 16194039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intravenous IgG for treatment of neuromuscular diseases].
    Vedeler CA; Mellgren SI; Omdal R; Torbergsen T; Aasly J
    Tidsskr Nor Laegeforen; 2010 Sep; 130(17):1717-20. PubMed ID: 20835282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adult-onset inflammatory myopathy: North Canterbury experience 1989-2001.
    Lynn SJ; Sawyers SM; Moller PW; O'Donnell JL; Chapman PT
    Intern Med J; 2005 Mar; 35(3):170-3. PubMed ID: 15737137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of immunoglobulin in severe childhood Guillain-Barré syndrome.
    Ortiz-Corredor F; Peña-Preciado M
    Acta Neurol Scand; 2007 Apr; 115(4):289-93. PubMed ID: 17376129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of intravenous immunoglobulin therapy for myositis: an audit in South Australian patients.
    Foreman C; Russo P; Davies N; Hissaria P; Proudman S; Hughes T; Limaye V
    Intern Med J; 2017 Jan; 47(1):112-115. PubMed ID: 28076913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic plasma exchange in neurologic disorders.
    Kes P
    Acta Med Croatica; 1997; 51(4-5):225-8. PubMed ID: 9473803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin.
    Cornblath DR; Chaudhry V; Griffin JW
    Ann Neurol; 1991 Jul; 30(1):104-6. PubMed ID: 1929221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Case of herpes zoster associated Guillain-Barré syndrome with a relapse of eruptions after intravenous immunoglobulin therapy].
    Nagane Y; Utsugisawa K; Obara D
    Rinsho Shinkeigaku; 2006 Sep; 46(9):664-7. PubMed ID: 17260813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of liquid intravenous immunoglobulin for neuroimmunologic disorders in the home setting: a retrospective analysis of 1085 infusions.
    Rigas M; Tandan R; Sterling RJ
    J Clin Neuromuscul Dis; 2008 Dec; 10(2):52-5. PubMed ID: 19169090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New indications for gamma globulins].
    Fontán G; García MC; Pascual-Salcedo D; López Trascasa M; Alvarez Doforno R; Ferreira A
    An Esp Pediatr; 1992 Jun; 36 Suppl 48():135-8. PubMed ID: 1379010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Guillain-Barré syndrome in children treated with intravenous immunoglobulin].
    Andersen UM
    Ugeskr Laeger; 1993 Oct; 155(42):3392-4. PubMed ID: 8259633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmapheresis for neurological disorders.
    Schröder A; Linker RA; Gold R
    Expert Rev Neurother; 2009 Sep; 9(9):1331-9. PubMed ID: 19769448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Usefulness of electromyography in diagnostics of the neuro-muscular diseases].
    Kroczka S; Steczkowska M; Kaciński M
    Przegl Lek; 2009; 66(11):913-9. PubMed ID: 20297628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.